Baba Ramdev’s Patanjali has launched a new pill called Coronil, which claims that it can cure coronavirus infection within a 14-day course of taking the medicine.
This medicine has been launched after joint research conducted by the National Institute of Medical Science, Jaipur, and Patanjali’s Research Institute in Haridwar. While talking about this, Baba Ramdev had said that this will be launched in all of their stores in the following week. He added that the medicine was tested in a placebo-controlled clinical trial with COVID-19 patients on a randomized testing basis.
The Indian Council for Medical Research, however, refused to endorse this, saying that that they do not deal with ayurvedic medicines, AYUSH Ministry does.
The Ayush Ministry came out in response to this, saying that Coronil is not to be marketed or advertised until all of the claims put forth by the Patanjali Group were proven to be credible. This comes following a statement issued by the ministry that said that advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules, and that the company is prohibited from advertisement, marketing, or selling of this medication without proper proof of approval. A Gazette Notification No. L.11011/8/2020/AS dated 21st April, 2020 was also issued probing about the details of the clinical trials and how they were conducted.
Notably, Patanjali claims of having licensed Coronil as a treatment for COVID-19 infections, to which the ministry has refuted requesting Uttarakhand Government’s Licensing Authority to furnish proper product approval details.